feed,title,long_url,short_url
Benzinga,Rhythm Pharma's Highlights Interim Setmelanotide Data In Long Term Genetic Disorder Trial,https://benzinga.com/general/biotech/22/02/25664617/rhythm-pharmas-highlights-interim-setmelanotide-data-in-long-term-genetic-disorder-trial,https://bit.ly/34Vqy0x
Benzinga,Enanta Pharma Commences Dosing In Phase 1 COVID-19 Trial,https://benzinga.com/general/biotech/22/02/25664016/enanta-pharma-commences-dosing-in-phase-1-covid-19-trial,https://bit.ly/3sJylqn
